| Application no. and date | 05852783.9 (espacenet) (Federated) (European Patent Register), 20051202 | | Patent/reg. no. and date | DK/EP 1830838, 20121003 | | Publication date | 20070912 | | Priority no. and date | US 633161 P, 20041203 | | EP pub. no. and date |
EP 1830838 20070912 | | Effective date | | | Applicant/owner | Dana-Farber Cancer Institute, Inc., 450 Brookline Avenue
Boston, MA 02215, US,
Triphase Research and Development I Corp., MaRS Centre
Heritage Building
101 College Street, Suite 340
Toronto ON M5G 1L7, CA | | Applicant ref. no. | LR/AP/145981 | | Inventor | ANDERSON, Kenneth, C., 264 Weston Road
Wellesley, Massachusetts 02481, US,
CHAUHAN, Dharminder, 8 Wedgewood Road
Natick, Massachusetts 01760, US,
PALLADINO,Michael A., 3357 Fortuna Ranch Road
Olivenhain
CA 92024, US | | Representative | Budde Schou A/S, Dronningens Tværgade 30, 1302 København K | | Opponent | | | IPC Class | A61K 31/397 (2006.01) , A61P 35/00 (2006.01) | | Title | Sammensætninger og fremgangsmåder til behandling af neoplastiske sygdomme | | Int. application no. | US2005043668 | | Int. publication no. | WO2006060676 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
